Related Experiment Video
Updated: Jun 1, 2026

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats
Published on: February 20, 2021
Phosphorylated toll-like receptor 4 defines a high-risk sepsis endotype
Madita Mühlhaus1, Birte Dyck1, Andrea Witowski1,2
1Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie, Ruhr-University Bochum, Knappschaft Kliniken Universitätsklinikum Bochum, Zentrum für perioperative Präzisionsmedizin, ZKF1, Universitätsstraße 150, Bochum, 44801, Germany.
Background:
Sepsis is a life-threatening condition characterized by a dysregulated immune response to infection. Toll-like receptor 4 plays a central role in pathogen recognition and inflammatory signalling and has been considered a key driver of sepsis pathophysiology. Pharmacological inhibition of this receptor showed beneficial effects in experimental models but failed in clinical trials. We therefore aimed to quantify in vivo activation of Toll-like receptor 4 in patients with sepsis and to determine its association with 30-day survival.
Methods:
Peripheral blood mononuclear cells were obtained from 100 patients with sepsis enrolled in the SepsisDataNet.NRW cohort. Samples were collected on day 1 (within 36 h after diagnosis) and day 4. Activation of TLR4 was quantified by measuring receptor phosphorylation using a validated proximity ligation assay. Survival analyses were performed using Kaplan-Meier curves and Cox proportional hazards regression models to assess the association between receptor activation and 30-day mortality.
Results:
Overall activation of TLR4 was low, with median values below one signal per cell at both day 1 and day 4. Despite the generally low levels, a subgroup of patients showed increased receptor activation. Higher activation was associated with significantly reduced 30-day survival. Patients with elevated activation had a higher risk of death both at day 1 (HR 2.03, 95% CI 1.01-4.07, p = 0.048) and day 4 (HR 2.77, 95% CI 1.14-6.73, p = 0.025). This association remained significant after adjustment for SOFA score at admission, age, infection focus and sex in multivariable Cox regression analysis (p = 0.006).
Conclusions:
In vivo activation of TLR4 is not uniformly present in patients with sepsis but occurs only in a subset of individuals. In those patients, increased activation is strongly associated with mortality. These findings suggest the presence of a distinct high-risk sepsis endotype characterized by enhanced receptor activation. This may help explain the failure of previous clinical trials of TLR4 inhibitors and supports the concept of biomarker-guided precision medicine approaches in sepsis.
Trial Registration:
German Clinical Trials Register (DRKS), DRKS00018871, retrospectively registered on 14 November 2019.
Insights
Toll-like receptor 4 (TLR4) activation in sepsis is not universal but present in a high-risk subgroup. Elevated TLR4 activation strongly correlates with increased 30-day mortality in sepsis patients.
Area of Science:
- Immunology
- Critical Care Medicine
- Molecular Biology
Background:
- Sepsis involves a dysregulated immune response to infection.
- Toll-like receptor 4 (TLR4) is crucial for pathogen recognition and inflammation.
- Previous TLR4 inhibitor trials in sepsis failed clinically despite preclinical success.
Purpose of the Study:
- Quantify in vivo TLR4 activation in sepsis patients.
- Determine the association between TLR4 activation and 30-day survival.
- Investigate TLR4 as a potential sepsis biomarker.
Main Methods:
- Collected peripheral blood mononuclear cells from 100 sepsis patients.
- Measured TLR4 activation via receptor phosphorylation using proximity ligation assay on days 1 and 4.
- Analyzed survival using Kaplan-Meier curves and Cox regression.
Main Results:
- Overall TLR4 activation was low, but a subset of patients exhibited increased activation.
- Higher TLR4 activation was significantly associated with reduced 30-day survival.
- Elevated activation increased mortality risk (Day 1 HR 2.03, Day 4 HR 2.77), independent of clinical factors.
Conclusions:
- In vivo TLR4 activation in sepsis is a phenotype present in a specific high-risk subgroup.
- Increased TLR4 activation is a strong predictor of mortality in sepsis.
- Findings support a precision medicine approach for sepsis treatment, potentially explaining prior trial failures.
Related Concept Videos
Formation of Lipopolysaccharides
Streptococcal Pharyngitis
Endocarditis IV: Nursing Management
Determinants of Bacterial Pathogenicity and Virulence
Bacterial Toxins
Endocarditis I: Introduction
